Increased circulating soluble LR11 in patients with acute coronary syndrome-Reference-Cited by-同舟云学术

Increased circulating soluble LR11 in patients with acute coronary syndrome

Published:2013-01 Issue: Volume:415 Page:191-194
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Ogita Manabu,Miyauchi Katsumi,Dohi Tomotaka,Tsuboi Shuta,Miyazaki Tadashi,Yokoyama Takayuki,Yokoyama Ken,Shimada Kazunori,Kurata Takeshi,Jiang Meizi,Bujo Hideaki,Daida Hiroyuki

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference26 articles.

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Lloyd-Jones;Circulation,2009

2. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment;Fox;Eur Heart J,2000

3. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): major international collaboration;WHO MONICA Project Principal Investigators;J Clin Epidemiol,1988

4. The pathogenesis of coronary artery disease and the acute coronary syndromes;Fuster;N Engl J Med,1992

5. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events;Waxman;Circulation,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis;2024-08-08

2. Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease;Circulation Journal;2021-09-16

3. Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients;BMC Nephrology;2020-06-15

4. Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention;International Heart Journal;2020-05-30

5. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia;Clinica Chimica Acta;2019-10